Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor

Jing Zhang, Orlando Piro, Lan Lu, George J. Broze

Research output: Contribution to journalArticlepeer-review

82 Scopus citations


Background - The endothelium is a major source of tissue factor pathway inhibitor (TFPI), the endogenous regulator of TF-induced coagulation, and a significant proportion of the expressed TFPI remains associated with the endothelial surface. Methods and Results - Phosphatidylinositol-specific phospholipase C (PI-PLC) treatment reduced TFPI at the surface of cultured endothelial cells by ≈80%, and at least a portion of the TFPI released by PI-PLC contained an intrinsic glycosylphosphatidylinositol (GPI) anchor that is recognized by anti-crossreactive determinant antibodies. Endothelial cells express both of the alternatively spliced forms of TFPI mRNA at a ratio of TFPIβ/TFPIα mRNA of ≈0.1 to 0.2. In Chinese hamster ovary (CHO) cells, TFPIα is predominantly secreted, whereas TFPIβ is a GPI-anchored membrane protein. Like TFPIβ, the small proportion of the TFPIα expressed by CHO cells that remains surface associated is also released by PI-PLC treatment, suggesting that it is bound to a separate GPI-anchored protein(s) at the surface of the cells. Conclusions - Both direct (TFPIβ) and indirect (TFPIα) GPI-mediated membrane anchorage is involved in localizing TFPI to the surface of cells.

Original languageEnglish
Pages (from-to)623-627
Number of pages5
Issue number5
StatePublished - Aug 5 2003


  • Coagulation
  • Endothelium-derived factors
  • Inhibitors

Fingerprint Dive into the research topics of 'Glycosyl phosphatidylinositol anchorage of tissue factor pathway inhibitor'. Together they form a unique fingerprint.

Cite this